Gilead Sciences Inc annual free cash flow for fiscal TTM was $10.2 billion, an increase of 8.2% from $9.5 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Free Cash Flow (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | $10.2B | $9.5B | $10.3B | $7.4B | $8.3B | $10.8B | $7.5B | $8.3B | $7.5B | $11.3B | $16.3B | $20.5B | $12.3B | $2.9B | $2.8B | $3.5B | $2.8B | $2.9B | $2.0B | $1.7B | $1.1B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Free Cash Flow (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Free Cash Flow (FCF) | $2.4B | $3.1B | $4.0B | $720M | $1.7B | $2.8B | $4.2B | $1.2B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More GILD metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Shares Outstanding
All GILD financial statements → Interactive GILD charts →
About TickerBase · Data methodology & sources